MSS51
gene geneOn this page
Also known as FLJ39565
Summary
MSS51 (MSS51 mitochondrial translational activator, HGNC:21000) is a protein-coding gene on chromosome 10q22.2, encoding Putative protein MSS51 homolog, mitochondrial (Q4VC12).
Predicted to enable zinc ion binding activity.
Source: NCBI Gene 118490 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 91 total
- MANE Select transcript:
NM_001024593
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21000 |
| Approved symbol | MSS51 |
| Name | MSS51 mitochondrial translational activator |
| Location | 10q22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ39565 |
| Ensembl gene | ENSG00000166343 |
| Ensembl biotype | protein_coding |
| OMIM | 614773 |
| Entrez | 118490 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000299432, ENST00000372912, ENST00000487126
RefSeq mRNA: 1 — MANE Select: NM_001024593
NM_001024593
CCDS: CCDS31221
Canonical transcript exons
ENST00000299432 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001221979 | 73433513 | 73433561 |
| ENSE00003593049 | 73425098 | 73425191 |
| ENSE00003645001 | 73423579 | 73424772 |
| ENSE00003890463 | 73426607 | 73426731 |
| ENSE00003890611 | 73428064 | 73428301 |
| ENSE00003893843 | 73425811 | 73426377 |
| ENSE00003894512 | 73427613 | 73427768 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 97.57.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1177 / max 47.3512, expressed in 19 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 110061 | 0.1177 | 19 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 97.57 | gold quality |
| quadriceps femoris | UBERON:0001377 | 96.82 | gold quality |
| biceps brachii | UBERON:0001507 | 96.62 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.19 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.06 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 93.84 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 92.34 | gold quality |
| muscle of leg | UBERON:0001383 | 91.48 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.37 | gold quality |
| muscle tissue | UBERON:0002385 | 88.72 | gold quality |
| deltoid | UBERON:0001476 | 87.23 | gold quality |
| tibialis anterior | UBERON:0001385 | 83.49 | silver quality |
| oviduct epithelium | UBERON:0004804 | 78.55 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.01 | gold quality |
| cerebellum | UBERON:0002037 | 74.85 | gold quality |
| apex of heart | UBERON:0002098 | 74.82 | gold quality |
| granulocyte | CL:0000094 | 74.67 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.22 | gold quality |
| heart left ventricle | UBERON:0002084 | 72.47 | gold quality |
| cardiac ventricle | UBERON:0002082 | 72.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.43 | gold quality |
| monocyte | CL:0000576 | 71.29 | gold quality |
| spleen | UBERON:0002106 | 71.26 | gold quality |
| leukocyte | CL:0000738 | 70.81 | gold quality |
| body of uterus | UBERON:0009853 | 70.54 | gold quality |
| lower esophagus | UBERON:0013473 | 70.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.65 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes are potential candidate genes for schizophrenia, especially in patients with deficits in sustained attention and executive function. (PMID:21531385)
- Yeast Translational Activator Mss51p and Human ZMYND17 - Two Proteins with a Common Origin, but Different Functions. (PMID:34565318)
- YTHDF2 regulates MSS51 expression contributing to mitochondria dysfunction of granulosa cells in polycystic ovarian syndrome patients. (PMID:38830447)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mss51 | ENSDARG00000075463 |
| mus_musculus | Mss51 | ENSMUSG00000021815 |
| rattus_norvegicus | Mss51 | ENSRNOG00000007632 |
| drosophila_melanogaster | Zmynd10 | FBGN0266709 |
Paralogs (2): ZMYND10 (ENSG00000004838), ZMYND19 (ENSG00000165724)
Protein
Protein identifiers
Putative protein MSS51 homolog, mitochondrial — Q4VC12 (reviewed: Q4VC12)
Alternative names: Zinc finger MYND domain-containing protein 17
All UniProt accessions (2): Q4VC12, F6VAV3
UniProt curated annotations — full annotation on UniProt →
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q4VC12-1 | 1 | yes |
| Q4VC12-2 | 2 | |
| Q4VC12-3 | 3 |
RefSeq proteins (1): NP_001019764* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002893 | Znf_MYND | Domain |
| IPR046824 | Mss51-like_C | Domain |
| IPR052839 | Mito_gene_expr_regulator | Family |
Pfam: PF01753, PF20179
UniProt features (16 total): binding site 8, splice variant 4, chain 1, zinc finger region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4VC12-F1 | 87.63 | 0.78 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 105; 108; 124; 127; 133; 137; 145; 149
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, IRF1_Q6, RYTAAWNNNTGAY_UNKNOWN, PITX2_Q2, AP4_Q6_01, STK33_SKM_UP, STK33_UP, LBP1_Q6, ZNF274_TARGET_GENES, ZNF563_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR520D_5P
GO Biological Process (0):
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
1281 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MSS51 | COX14 | Q96I36 | 802 |
| MSS51 | COA1 | Q9GZY4 | 754 |
| MSS51 | COX5A | P20674 | 731 |
| MSS51 | COA3 | Q9Y2R0 | 716 |
| MSS51 | TACO1 | Q9BSH4 | 678 |
| MSS51 | COX15 | Q7KZN9 | 576 |
| MSS51 | SURF1 | Q15526 | 543 |
| MSS51 | PET117 | Q6UWS5 | 531 |
| MSS51 | COX10 | Q12887 | 519 |
| MSS51 | COX20 | Q5RI15 | 507 |
| MSS51 | COX11 | Q9Y6N1 | 496 |
| MSS51 | COX19 | Q49B96 | 487 |
| MSS51 | COX4I2 | Q96KJ9 | 471 |
| MSS51 | PET100 | P0DJ07 | 456 |
| MSS51 | IGFN1 | Q86VF2 | 452 |
IntAct
69 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MSS51 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | CTNNBIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | BEX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | TFG | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | KANK2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GEM | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEACAM6 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | HOMER3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | TOLLIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | SNX18 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR35 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAJB13 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | MGC50722 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDKN2D | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLE5 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | DTX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO1 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMU1 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSS51 | SEMG1 | psi-mi:“MI:0914”(association) | 0.530 |
| DUX4L9 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PICK1 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CTNNBIP1 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BEX2 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TFG | MSS51 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KANK2 | MSS51 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): SEMG1 (Affinity Capture-MS), SEMG2 (Affinity Capture-MS), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid)
ESM2 similar proteins: A0JMQ9, A2BD94, A2RRT3, A7YY07, A8WHR0, B2RYN2, B3M1F2, B3MJV4, B4HWV2, B4N8G7, B5E0H4, D3ZKV9, F5HB62, O36371, O43147, P03177, P41958, Q0D2D2, Q1HVD1, Q1L8G6, Q1LVQ2, Q2NKQ1, Q3KSQ2, Q3TQF0, Q4V8Z3, Q4VC12, Q5U430, Q5XUX0, Q66624, Q68FS7, Q6INH1, Q6ZRS2, Q6ZT12, Q7ZUL9, Q80U12, Q84WW1, Q8AXQ3, Q8BFX3, Q8BMQ2, Q8BPQ7
Diamond homologs: A9CPT4, C3RZA1, D3ZKV9, E1C5V0, F1QN74, F1RET2, O74467, P97443, Q0P585, Q12529, Q3TYX3, Q4VC12, Q5BJI7, Q5F3V0, Q5R5X9, Q5RGL7, Q5UNT8, Q5ZIZ2, Q6C9E7, Q6GMV2, Q6GN68, Q6GPQ4, Q7M6Z3, Q7TSV3, Q7ZXV5, Q8BTK5, Q8IYR2, Q8NB12, Q8R5A0, Q91YE3, Q96E35, Q9BXT4, Q9CQG3, Q9CWR2, Q9D5Z5, Q9GZT9, Q9H7B4, Q9N3Q8, Q9NRG4, Q9VU41
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1017 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:73428062:A:AC | donor_gain | 1.0000 |
| 10:73428063:C:CC | donor_gain | 1.0000 |
| 10:73429612:CA:C | donor_gain | 1.0000 |
| 10:73424770:TGG:T | acceptor_gain | 0.9900 |
| 10:73424773:C:CC | acceptor_gain | 0.9900 |
| 10:73425073:A:AC | donor_gain | 0.9900 |
| 10:73425099:TGTAA:T | donor_gain | 0.9900 |
| 10:73426137:AGG:A | donor_gain | 0.9900 |
| 10:73426547:T:TA | donor_gain | 0.9900 |
| 10:73426595:C:CT | donor_gain | 0.9900 |
| 10:73426608:TGTG:T | donor_gain | 0.9900 |
| 10:73429612:CACT:C | donor_gain | 0.9900 |
| 10:73433508:CTTA:C | donor_loss | 0.9900 |
| 10:73433509:TTA:T | donor_loss | 0.9900 |
| 10:73433510:TA:T | donor_loss | 0.9900 |
| 10:73433511:A:AC | donor_gain | 0.9900 |
| 10:73433511:AC:A | donor_gain | 0.9900 |
| 10:73433512:C:CC | donor_gain | 0.9900 |
| 10:73433512:CC:C | donor_gain | 0.9900 |
| 10:73433512:CCCTG:C | donor_gain | 0.9900 |
| 10:73424771:GG:G | acceptor_gain | 0.9800 |
| 10:73424775:G:C | acceptor_gain | 0.9800 |
| 10:73425127:A:AC | donor_gain | 0.9800 |
| 10:73425127:ATAGT:A | donor_gain | 0.9800 |
| 10:73426596:C:CT | donor_gain | 0.9800 |
| 10:73427694:T:TA | donor_gain | 0.9800 |
| 10:73428067:T:C | donor_gain | 0.9800 |
| 10:73428313:A:C | acceptor_gain | 0.9800 |
| 10:73433511:ACC:A | donor_gain | 0.9800 |
| 10:73433512:CCC:C | donor_gain | 0.9800 |
AlphaMissense
2973 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:73425159:A:G | W368R | 0.987 |
| 10:73425159:A:T | W368R | 0.987 |
| 10:73425886:A:C | Y332D | 0.980 |
| 10:73425188:A:G | F358S | 0.975 |
| 10:73425134:C:G | R376P | 0.973 |
| 10:73427678:G:C | F104L | 0.969 |
| 10:73427678:G:T | F104L | 0.969 |
| 10:73427680:A:G | F104L | 0.969 |
| 10:73426676:G:C | H145D | 0.967 |
| 10:73424700:A:C | N412K | 0.966 |
| 10:73424700:A:T | N412K | 0.966 |
| 10:73425818:G:C | F354L | 0.965 |
| 10:73425818:G:T | F354L | 0.965 |
| 10:73425820:A:G | F354L | 0.965 |
| 10:73424634:A:C | S434R | 0.964 |
| 10:73424634:A:T | S434R | 0.964 |
| 10:73424636:T:G | S434R | 0.964 |
| 10:73425886:A:T | Y332N | 0.963 |
| 10:73426637:C:G | D158H | 0.961 |
| 10:73424682:T:A | K418N | 0.960 |
| 10:73424682:T:G | K418N | 0.960 |
| 10:73425146:A:G | L372P | 0.959 |
| 10:73428144:G:C | F47L | 0.959 |
| 10:73428144:G:T | F47L | 0.959 |
| 10:73428146:A:G | F47L | 0.959 |
| 10:73426729:C:G | C127S | 0.958 |
| 10:73426730:A:T | C127S | 0.958 |
| 10:73424753:A:G | S395P | 0.956 |
| 10:73425976:C:G | G302R | 0.955 |
| 10:73426312:A:G | W190R | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000924322 (10:73432896 G>A), RS1000935773 (10:73429230 A>G), RS1001323310 (10:73428232 G>A), RS1001679809 (10:73434802 C>G,T), RS1001832791 (10:73432089 A>G), RS1002108371 (10:73432946 A>G), RS1002192848 (10:73434544 G>T), RS1002384790 (10:73425661 C>A), RS1002869825 (10:73428002 C>A,T), RS1003265018 (10:73425208 A>G), RS1003385234 (10:73434907 G>A), RS1003416522 (10:73435265 T>C), RS1004115017 (10:73429693 G>A), RS1004128755 (10:73425705 A>C,G,T), RS1004183018 (10:73431365 T>C,G)
Disease associations
OMIM: gene MIM:614773 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 3 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| clothianidin | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.